Dental caries and periodontal disease in children and adolescents with inflammatory bowel disease: A case-control study

Inflammatory Bowel Diseases

Volumn 21, Issue 8, 2015, Pages 1839-1846

  Koutsochristou, Vassiliki ^a   Zellos, Aglaia ^a   Dimakou, Konstantina ^a   Panayotou, Ioanna ^a   Siahanidou, Sultana ^a   Roma Giannikou, Eleftheria ^a   Tsami, Alexandra ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adolescents; Children; Dental caries; Gingival inflammation; Inflammatory bowel disease; Periodontal treatment needs

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DENTAL CARIES; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PERIODONTAL DISEASE; PERIODONTIUM; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; TOOTH BRUSHING; ADULT; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; PERIODONTAL DISEASES; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENTAL CARIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PERIODONTAL DISEASES; PROGNOSIS; YOUNG ADULT;

EID: 84946901860     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000452     Document Type: Article

References (61)

1. MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol. 2000;51:2-9.
2. Jostins L, Ripke S, Weersma RK. Host- microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
3. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237-247.
4. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
5. Soon IS, Molodecky NA, Rabi MD, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12:51.
6. Bernstein CN, Shanahan F Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185-1191.
7. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471.
8. Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease - a nationwide, register-based Finnish case-control study. Am J Epidemiol. 2012;175:775-784.
9. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7:235-241.
10. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, Central China. Inflamm Bowel Dis. 2006;12:212-217.
11. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol. 1991;13:29-37.
12. Williams AJK, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med. 1991;79:451-458.
13. Chan SW, Scully C, Prime SS, et al. Pyostomatitis vegetans: oral manifestation of ulcerative colitis. Oral Surg Oral Med Oral Pathol. 1991;72:689-692.
14. Lisciandrano D, Ranzi T, Carrassi A, et al. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastrenterol. 1996;91:7-10.
15. Dupuy A, Cosnes J, Revuz J, et al. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol. 1999;135:439-442.
16. Dudeney TP. Crohn's disease of the mouth. Proc R Soc Med. 1969;62:1237.
17. Carr D. Granulomatous cheilitis in Crohn's disease. Br Med J. 1974;4:636.
18. Snyder MB, Cawson RA. Oral changes in Crohn's disease. J Oral Surg. 1976;34:594-599.
19. Talbot T, Jewell L, Schloss E, et al. Cheilitis antedating Crohn's disease: case report and literature update of oral lesions. J Clin Gastroenterol. 1984;6:349-354.
20. Scheper HJ, Brand HS. Oral aspects of Crohn's disease. Int Dent J. 2002;52:163-172.
21. Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol. 2005;3:886-891.
22. Hansen LS, Silverman S Jr, Daniels TE. The differential diagnosis of pyostomatitis vegetans and its relation to bowel disease. Oral Surg Oral Med Oral Pathol. 1983;55:363-373.
23. Sundh B, Hultén L. Oral status in patients with Crohn's disease. Acta Chir Scand. 1982;148:531-534.
24. Rooney TP. Dental caries prevalence in patients with Crohn's disease. Oral Surg Oral Med Oral Pathol. 1984;57:623-624.
25. Bevenius J. Caries risk in patients with Crohn's disease: a pilot study. Oral Surg Oral Med Oral Pathol. 1988;65:304-307.
26. Sundh B, Emilson CG. Salivary and microbial conditions and dental health in patients with Crohn's disease: a 3-year study. Oral Surg Oral Med Oral Pathol. 1989;67:286-290.
27. Schütz T, Drude C, Paulisch E, et al. Sugar intake, taste changes and dental health in Crohn's disease. Dig Dis. 2003;21:252-257.
28. Grössner-Scheiber B, Fetter T, Hedderich J, et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33:478-484.
29. Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol. 2008;35:555-560.
30. Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol. 1991;18:690-697.
31. Meurman JH, Halme L, Laine P, et al. Gingival and dental status, salivary acidogenic bacteria, and yeast counts of patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol. 1994;77:465-468.
32. Habashneh RA, Khader YS, Alhumouz MK, et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. J Periodontal Res. 2012;47:293-298.
33. Vavricka SR, Manser CN, Hediger S, et al. Periodontitis and gingivitis in inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2013;19:2768-2777.
34. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
35. Registram-General. Classification of Occupations. London, United Kingdom: HMSP; 1960.
36. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
37. Turner D, Hyams J, Markowitz J, et al. Appraisal of the pediatric ulcerative colitis activity index. Inflamm Bowel Dis. 2009;15:1218-1223.
38. World Health Organization. Oral Health Surveys: Basic Methods. 4th ed. Geneva, Switzerland: WHO; 1997.
39. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972;43:38.
40. Lindhe J. Textbook of Clinical Periodontology. 1st ed. Copenhagen, Denmark: Munksgaard; 1981:327-352.
41. Ainamo J, Barmes D, Beagrie G, et al. Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J. 1982;32:281-291.
42. Tsami A, Pepelassi E, Kontovazenitis G, et al. Frequency and distribution of furcation defects in chronic periodontitis patients. Hellenic Stomatological Rev. 2008;52:25-35.
43. Basu MK, Asquith P, Thompson RA, et al. Proceedings: oral lesions in patients with Crohn's disease. Gut. 1974;15:346.
44. Taylor VE, Smith CJ. Oral manifestations of Crohn's disease without demonstrable gastrointestinal lesions. Oral Surg Oral Med Oral Pathol. 1975;39:58-66.
45. Basu MK. Oral manifestations of Crohn's disease: studies in the pathogenesis. Proc R Soc Med. 1976;69:765-766.
46. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
47. Wysocki GP, Brooke RI. Oral manifestations of chronic granulomatous disease. Oral Surg Oral Med Oral Pathol. 1978;46:815-819.
48. Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol. 1980;9:307-321.
49. Fisher AA. Chronic lip edema with particular reference to the Melkersson-Rosenthal syndrome (MRS). Cutis. 1990;45:144-146.
50. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am. 1990;74:39-50.
51. Rehberger A, Püspök A, Stallmeister T, et al. Crohn's disease masquerading as aphthous ulcers. Eur J Dermatol. 1998;8:274-276.
52. Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Pediatr. 2001;138:767-771.
53. Vehkalathi M, Paunio I, Nyyssonen V, et al. Oral Health in the Adult Finnish Population and Associated Factors. Helsinki and Turku, Finland: Social Insurance Institution; 1999:237-252.
54. Halme L, Meurman JH, Laine P, et al. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol. 1993;76:175-181.
55. Said HS, Suda W, Nakagome S, et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res. 2014;21:15-25.
56. Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986;53:671-677.
57. Sigusch BW. Periodontitis as manifestation of Crohn's disease in primary dentition: a case report. J Dent Child. 2004;71:193-196.
58. Seymour RA, Heasman PA. Drugs and periodontium. J Clin Periodontol. 1988;15:1-16.
59. Santi E, Bral M. Effect of treatment on cyclosporine and nifedipine induced gingival enlargement: clinical and histologic results. Int J Periodontics Restorative Dent. 1998;18:81-86.
60. Seymour RA, Ellis JS, Thomson JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000;27:217-230.
61. Pistorius A, Willershausen B, Callaway A. Effects of selected immunoupressive drugs on prostaglandin release, protein synthesis and cell proliferation in human fibroblasts and on the growth of plaque bacteria. Eur J Med Res. 2003;28:25-32.